Alzheimer's disease (AD), also known as Alzheimer disease, is the most common form of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include confusion, irritability, aggression, mood swings, trouble with language, and long-term memory loss. As a person's condition declines they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is approximately seven years. Fewer than 3% of individuals live more than 14 years after diagnosis.
Alzheimer's disease is classified as a neurodegenerative disorder, the cause and progression of which are poorly understood. The disease process appears to be associated with plaques and tangles in the brain. Initial symptoms are often mistaken for 'age-related' concerns, or manifestations of stress. The diagnosis is usually confirmed with tests that evaluate behavior and thinking abilities, often followed by a brain scan. Examination of brain tissue; however, is required for a definite diagnosis. Mental stimulation, exercise, and a balanced diet have been suggested as ways to delay cognitive symptoms (though not brain pathology) in healthy older individuals, but there is no conclusive evidence supporting an effect.
No treatments stop or reverse its progression, though some may temporarily lessen symptoms. Because AD is progressive, the affected person increasingly relies on others for assistance. The role of the main caregiver is often taken by the spouse or a close relative. It may place a great burden on caregivers; the pressures can be wide-ranging, involving social, psychological, physical, and economic elements of the caregiver's life.
Most often, AD is diagnosed in people over 65 years of age, although the less-common early-onset Alzheimer's can occur in much younger people. In 2006, there were 26.6 million people worldwide with AD. Alzheimer's is predicted to affect 1 in 85 individuals globally by 2050. It was first described by (and later named after) German psychiatrist and neuropathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most costly diseases to society. As of 2014, more than 1,500 clinical trials have been or are being conducted to test various treatments in AD. Read more ...
An additional 42 genes connected to the development of Alzheimer's disease have been uncovered in the largest study of genetic risk for Alzheimer's to date CNN - April 7, 2022
This is a landmark study in the field of Alzheimer's research and the culmination of 30 years' work. 60-80% of disease risk is based on our genetics and therefore we must continue to seek out the biological causes and develop much-needed treatments for the millions of people affected worldwide. Many people confuse this impairment, often called MCI, with normal aging, but it is different -- around one-third of people with mild cognitive impairment develop dementia due to Alzheimer's disease within five years, according to the research. Depending on the type of MCI people have, they might have trouble remembering conversations, keeping track of things, maintaining their train of thought during a conversation, navigating a usually familiar place or completing everyday tasks, such as paying a bill. Some individuals don't increasingly decline, and others revert to normal function, according to the report.
Most people don't know these possible signs of early Alzheimer's CNN - March 15, 2022
If you're not familiar with the term "mild cognitive impairment," you're not the only one. More than 80% of Americans aren't familiar with this condition that affects up to 18% of people ages 60 and older and can lead to Alzheimer's disease, a new survey has found. Mild cognitive impairment is an early stage of subtle memory loss or other cognitive ability loss, such as language or visual/spatial perception, according to research published Tuesday in the Alzheimer's Association's 2022 Alzheimer's Disease Facts and Figures report. The signs can be serious enough to be noticed by the affected person and loved ones, yet mild enough that the affected person can maintain their ability to do most activities of daily living.
Signs of Alzheimer's disease may be detectable before significant symptoms are obvious Medical Express - October 7, 2021
Healthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores relating to reasoning and attention, according to a new study.
Researchers uncover epigenetic drivers for Alzheimer's disease Medical Express - September 28, 2020
New findings suggest that late-onset Alzheimer's Disease is driven by epigenetic changes how and when certain genes are turned on and off in the brain. Epigenetic changes alter gene expression without DNA mutation, but rather by marking proteins that package and protect DNA, called histones
Research confirms link between sleep apnea and Alzheimer's disease Medical Express - September 28, 2020
The study showed the severity of sleep apnea was linked with a corresponding build-up of amyloid plaques. New research has confirmed long-suspected links between sleep apnea and Alzheimer's disease, finding identical signs of brain damage in both conditions. While the cause of Alzheimer's disease remains a mystery, amyloid plaques that are toxic to brain cells are known indicators of the disease. The new research showed these plaques start in the same place and spread in the same way in the brains of people with obstructive sleep apnea, as in those with Alzheimer's.
Cells study helping to crack the code to Alzheimer's disease Medical Express - June 25, 2019
Alzheimer's disease is the most common form of dementia in older people and, as there are no effective treatments, is one of the leading contributors to the global disease burden. Various genes have been implicated in the changes that happen in the brains of Alzheimer's patients. What is not known is how the activity of the genes - called gene expression - affects the many different cells of the brain. The study ....
Consistent gene changes in Alzheimer's disease across studies Medical Express - June 25, 2019
A comparison of mouse Alzheimer's disease models shows changes in the number of cells and the genes they express remain consistent throughout all stages of the disease.
New blood test for detecting Alzheimer's disease Medical Express - June 25, 2019
Researchers have developed a method to create a new blood marker capable of detecting whether or not a person has Alzheimer's disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.
A first-of-its-kind national study has found that a form of brain imaging that detects Alzheimer's-related "plaques" significantly influenced clinical management of patients with mild cognitive impairment and dementia Medical Express - April 2, 2019
The study revealed that providing clinicians with the results of positron emission tomography (PET) scans that identify amyloid plaques in the brain changed medical management - including the use of medications and counseling - in nearly two-thirds of cases, more than double what researchers predicted in advance of the study. The technique, known as "amyloid PET imaging," also altered the diagnosis of the cause of cognitive impairment in more than one in three study participants
Alzheimer's-like symptoms reversed in mice - Special diet with compounds contained in green tea and carrots restored working memory Science Daily - March 6, 2019
Nevertheless, the findings lend credence to the idea that certain readily available, plant-based supplements might offer protection against dementia in humans.
What Defines Different Dementias? Alzheimer's disease is the most common form of dementia among older people Live Science - October 24, 2018
Typically, the first symptoms of the disease are difficulties with short-term memory, such as having trouble remembering recent conversations, events or people's names. Other early symptoms can include having trouble finding words during conversations or reduced problem-solving abilities, such as in managing finances. Depression and loss of interest in some activities are also common.
Scientists reveal ground-breaking plan to target cause of Alzheimer's disease Medical Express - September 24, 2018
A breakthrough has been made in the fight against Alzheimer's disease—researchers have found a new way to target the toxic particles that destroy healthy brain cells. This is the first time that a systematic method to go after the pathogens - the cause of Alzheimer's disease - has been proposed. Until very recently scientists couldn't agree on what the cause was so we didn't have a target. As the pathogens have now been identified as small clumps of proteins known as oligomers, we have been able to develop a strategy to aim drugs at these toxic particles.
Music activates regions of the brain spared by Alzheimer's disease PhysOrg - April 27, 2018
Ever get chills listening to a particularly moving piece of music? You can thank the salience network of the brain for that emotional joint. Surprisingly, this region also remains an island of remembrance that is spared from the ravages of Alzheimer's disease.
Which genetic marker is the ring leader in the onset of Alzheimer's disease? Medical Express - September 4, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf. Researchers have found that another gene, TOMM40, complicates the picture. Although ApoE4 plays a greater role in some types of aging-related memory ability, the researchers believe that TOMM40 may pose an even greater risk for other types. TOMM40 and APOE genes are neighbors, adjacent to each other on chromosome 19, and they are sometimes used as proxies for one another in genetic studies. At times, scientific research has focused chiefly on one APOE variant, ApoE4, as the No. 1 suspect behind Alzheimer's and dementia-related memory decline. The literature also considers the more common variant of APOE, ApoE3, neutral in risk for Alzheimer's.
To Understand Sex Differences In Alzheimer's Disease, We Need To Understand Risk Factors Across The Lifespan Huffington Post - July 11, 2017
The long course of Alzheimer’s disease: Put simply, Alzheimer’s disease (AD) can be conceptualized as two stages: a clinically silent stage, where brain pathologies are present, but symptoms are absent; and a symptomatic stage, where individuals show signs of dementia (this typically involves memory impairment as well as an inability to live independently). Although there is debate regarding what criteria should be used to classify the clinically silent stage, there is consensus in the field that the pathological drivers of AD, the brain accumulation of amyloid and tau proteins, begin decades before symptoms occur.
6 Big Mysteries of Alzheimer's Disease Live Science - September 26, 2016
Despite intensive, worldwide research efforts for more than three decades to better understand Alzheimer's disease, there are still numerous mysteries surrounding the condition. Alzheimer's disease is a slowly progressing brain disorder. In people with the condition, abnormal deposits of a protein called amyloid-beta forms sticky plaques in the brain, and strands of the protein tau twist around, causing tangles that ultimately kill brain cells and cause a loss of memory, thinking and reasoning skills. About 5.4 million Americans currently have Alzheimer's disease, and the number is expected to grow rapidly in the coming years as a larger share of the population ages, according to the Centers for Disease Control and Prevention.
Alzheimer's stemmed but not stopped, say experts Medical Express - September 19, 2016
Soaring rates of population growth and aging have long been seen as portending a global explosion of Alzheimer's, the debilitating disease that robs older people of their memory and independence. But an unexpected, and hopeful, trend may be emerging. In rich countries at least, recent data suggests the rate of new cases has slowed or even reversed - a tantalizing hint that quality-of-life improvements may protect against dementia.
Alzheimer's gene may show effects on brain starting in childhood Science Daily - July 14, 2016
A gene associated with Alzheimer's disease and recovery after brain injury may show its effects on the brain and thinking skills as early as childhood, according to a new study. A gene associated with Alzheimer's disease and recovery after brain injury may show its effects on the brain and thinking skills as early as childhood.
New link found between diabetes and Alzheimer's disease Medical Express - June 21, 2016
The study reports that Alzheimer's Disease and type 2 diabetes are so closely related that drugs currently used to control glucose levels in diabetes may also alleviate the symptoms and progression of Alzheimer's disease. Research found for the first time that dementia-related complications within the brain can also lead to changes in glucose handling and ultimately diabetes. This is contrary to what was previously thought - that diabetes begins with a malfunction in the pancreas or a high fat, high sugar diet.
Men may get head start on Alzheimer's treatment, study says CNN - March 16, 2016
If you're a woman who has just been diagnosed with mild cognitive decline or Alzheimer's, you might have missed out on years of treatment that could have slowed your disease progression. That's the takeaway from a new study that compared how men and women with varying stages of memory loss respond to verbal learning tests, a key method for diagnosing Alzheimer's and other memory disorders. The female advantage in verbal memory may allow women to maintain normal cognitive function for longer as the disease progresses.
Novel Chemical 'Washes Away' Alzheimer's Plaque in Mice Live Science - December 9, 2015
Scientists in Korea have found a small molecule that, when added to the drinking water of mice bred to develop Alzheimer's disease, washed away the protein plaques associated with the disease and improved the mice's learning and memory functions. The chemical, called EPPS - short for 4-(2-hydroxyethyl)-1- piperazinepropanesulphonic acid - posed no ill effect for the mice even at high doses. The scientists hope to conduct further studies to determine whether the EPPS is safe and effective for humans with Alzheimer's disease.
DNA repair protein BRCA1 implicated in cognitive function and dementia Science Daily - November 30, 2015
Researchers have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer's disease. BRCA1 is a key protein involved in DNA repair, and mutations that impair its function increase the risk for breast and ovarian cancer. The new study demonstrates that Alzheimer's disease is associated with a depletion of BRCA1 in neurons and that BRCA1 depletion can cause cognitive deficits.
Virtual reality maze predicts Alzheimer's disease BBC - October 24, 2015
Alzheimer's disease can be detected decades before onset, using a virtual reality test, a study suggests. People aged 18 to 30 were asked to navigate through a virtual maze to test the function of certain brain cells. Those with a high genetic risk of Alzheimer's could be identified by their performance, according to German neuroscientists.
Alzheimer's Risk: Women with Memory Problems Decline Faster Than Men Live Science - July 21, 2015
Elderly women are more likely than elderly men to develop Alzheimer's disease, even when they are exposed to some of the same risk factors, two new studies find. Senior women who have mild cognitive problems, such as memory impairment and difficulties with language or thinking skills, decline in cognitive ability twice as fast as men who also have mild cognitive impairment, according to one study. A separate study found that women declined more dramatically than men in measures of cognition, function and brain size after they underwent surgery and general anesthesia.
Drug restores brain function and memory in early Alzheimer's disease Science Daily - March 11, 2015
An existing epilepsy drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer's disease. novel therapeutic approach for an existing drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer's disease, researchers at Johns Hopkins University found. The drug, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI), a clinically recognized condition in which memory impairment is greater than expected for a person's age and which greatly increases risk for Alzheimer's dementia.
New non-invasive method can detect Alzheimer's disease early Science Daily - December 23, 2014
A noninvasive MRI approach that can detect the Alzheimer's disease in a living animal, well before typical Alzheimer's symptoms appear, has been developed by researchers. The research team created an MRI probe that pairs a magnetic nanostructure with an antibody that seeks out the amyloid beta brain toxins responsible for onset of the disease. The accumulated toxins, because of the associated magnetic nanostructures, show up as dark areas in MRI scans of the brain.
Imaging shows brain connection breakdown in early Alzheimer's disease PhysOrg - December 1, 2014
Changes in brain connections visible on MRI could represent an imaging biomarker of Alzheimer's disease. Alzheimer's disease is the most common form of dementia. As many as 5 million Americans are affected, a number expected to grow to 14 million by 2050. Preventive treatments may be most effective before Alzheimer's disease is diagnosed, such as when a person is suffering from mild cognitive impairment (MCI), a decline in cognitive skills that is noticeable but not severe enough to affect independent function. Previous efforts at early detection have focused on beta amyloid, a protein found in abnormally high amounts in the brains of people with Alzheimer's disease.
Bilingualism delays Alzheimer manifestation by more than four years PhysOrg - December 1, 2014
Between March 2013 and May 2014, 69 monolingual and 65 bilingual Belgian patients suffering from probable Alzheimer's disease (AD) participated in the study. Psychologists Evy Woumans, MichaĎl Stevens, and Wouter Duyck, together with neurologists Patrick Santens, Anne Sieben, and Jan Versijpt determined the age of AD manifestation and AD diagnosis for both language groups.
Different forms of Alzheimer's have similar effects on brain networks PhysOrg - August 28, 2014
Brain networks break down similarly in rare, inherited forms of Alzheimer's disease and much more common uninherited versions of the disorder, a new study has revealed. Scientists at Washington University School of Medicine in St. Louis have shown that in both types of Alzheimer's, a basic component of brain function starts to decline about five years before symptoms, such as memory loss, become obvious. The breakdown occurs in resting state functional connectivity, which involves groups of brain regions with activity levels that rise and fall in coordination with each other. Scientists believe this synchronization helps the regions form networks that work together or stay out of each other's way during mental tasks.
Rescue of Alzheimer's memory deficit achieved by reducing 'excessive inhibition' PhysOrg - June 13, 2014
A new drug target to fight Alzheimer's disease has been discovered by a research team led by Gong Chen, a Professor of Biology and the Verne M. Willaman Chair in Life Sciences at Penn State University. The discovery also has potential for development as a novel diagnostic tool for Alzheimer's disease, which is the most common form of dementia and one for which no cure has yet been found.
Study shows where Alzheimer's starts and how it spreads PhysOrg - December 23, 2013
Alzheimer's disease starts in the entorhinal cortex (yellow). Using fMRI in mouse (left) and human (right) brains, the researchers provide evidence that the disease spreads from the entohrinal cortex (yellow) to other cortical regions (red) - the perirhinal cortex and posterior parietal cortex.
Dementia cases 'set to treble worldwide' by 2050 BBC - December 5, 2013
The number of people living with dementia worldwide is set to treble by 2050, according to a new analysis. Alzheimer's Disease International says 44 million people live with the disease, but that figure will increase to 135 million by 2050. Alzheimer's Disease International expects increasing life expectancies to drive a surge in cases in poor and middle-income countries, particularly in South East Asia and Africa. Currently 38% of cases are in rich countries. But that balance is predicted shift significantly by 2050, with 71% of patients being in poor and middle-income countries.
Molecular Trigger for Alzheimer's Disease Identified Science Daily - May 21, 2013
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons in the brain. For the first time, scientists at Cambridge's Department of Chemistry have been able to map in detail the pathway that generates aberrant forms of proteins which are at the root of neurodegenerative conditions such as Alzheimer's. They believe the breakthrough is a vital step closer to increased capabilities for earlier diagnosis of neurological disorders such as Alzheimer's and Parkinson's, and opens up possibilities for a new generation of targeted drugs, as scientists say they have uncovered the earliest stages of the development of Alzheimer's that drugs could possibly target.
Scientists Reverse Memory Loss in Animal Brain Cells Science Daily - April 17, 2013
Neuroscientists at The University of Texas Health Science Center at Houston (UTHealth) have taken a major step in their efforts to help people with memory loss tied to brain disorders such as Alzheimer's disease. Using sea snail nerve cells, the scientists reversed memory loss by determining when the cells were primed for learning. The scientists were able to help the cells compensate for memory loss by retraining them through the use of optimized training schedules.
ALTERNATIVE HEALING INDEX
CRYSTALINKS HOME PAGE
PSYCHIC READING WITH ELLIE
BOOK: THE ALCHEMY OF TIME
DONATION TO CRYSTALINKS
ADVERTISE ON CRYSTALINKS